Please enable JavaScript.
Coggle requires JavaScript to display documents.
L32: Drug-Drug Interactions (Phamacokinetic (Absorption :!: (DDIs within…
L32: Drug-Drug Interactions
Pharmacodynamic
Opposing Effects
(A)Antagonist + (B)Agonist (Receptor mediated)
Propranolol(A) + Salbutamol(B) - Beta2 R
A decreases efficacy of B
Exacerbate Obstructive Airways Diseases
Naloxone(A) + Morphine(B)
A decreases efficacy of B
Naloxone: reversal agent in opioid overdose/ induce opioid withdrawal
Non-Receptor Mediated
Warfarin + Vitamin K
:!:
Wafarin Inhibit Vit. K
Consuming Vit. K can reduce efficacy of Warfarin
Nonsteroidal anti-inflammatory drug (NSAIDs)
with Antihypertensive medication (ACE inhibitors/thiazides)
diminish antihypertensive action with NSAIDs
with Diuretics
reduce efficacy of diuretics in chronic heart failure treatment
Additive Effects
Non-Receptor Mediated
Warfarin
with Antibiotics
Antibiotics inhibit Vit. K production; increase Warfarin's anticoagulant activity.
with Aspirin
Increase risk of bleeding (GI Tract); Aspirin is also an anticoagulant
Diuretics(K+ depleting) + Digoxin
:!:
Hypokalaemia is induced by diuretics which can potentiate digoxin toxicity
Drug-Food Interaction
Hypertensive Crisis
Mono-oxidase Inhibitors(MAOIs)-Tranylcypromine,
phenelzine
:!:
with food containing Tyramine :forbidden: :!: - Fermented Food
Death - Intracranial Haemorrhage
with Food contain Sympathomimetics -
Pseudoephedrine
(cough & cold remedies)
Hypertensive Crises
Serotonin Syndrome
2 Serotonergic Drugs > Overdose of serotonin :forbidden:
MAOIs
Tricyclic Antidepressants
:!:
SSRIs (Selective Serotonin re-uptake Inhibitors
OTC: St John's wort,
Dextromethorphan
(common cough suppression)
Analgesics: tramadol, pethidine, fentanyl
Illicit drugs: amphetamine, cocaine, ecstasy
Duromine (appetite supressant)
Features
Altered Mental Status (agitation, confusion, mad)
Autonomic Dysfunction (diaphoresis, diarrhoea, fever, shiver)
Neuromuscular Abnormalities
Phamacokinetic
Metabolism
Enzyme Inducer
Exaggerated clinical response with CYP-dependent 'pro-drug'
Rifampicin (CYP3A4 inducer)
with
Clopidogrel
(anti-platelet drug)
Toxicity due to enhance production of Toxic Metabolite
Carbamazepine / phenobarbitone /
phenytoin / isoniazid / rifampicin (CYP2E1 Inducers)
with
Paracetamol
overdose > increase toxic metabolite (
NAPQI
)
Loss of efficacy of parent drug
Rifampicin (2C9 inducer)
with Wafarin (2C9 substrate)
Carbamazepine/Phenytoin OR Rifampicin (CYP3A4 inducer)
with Combined Oral Contraceptive pill (COCP) > Contraceptive Failure
Enzyme Inhibitor
Blood levels of drug exceed toxic threshold
Clarithromycin :!: / Ritonavir (CYP3A4 Inhibitor)
with Statins (Atorvastatin / Simvastatin) >
myopathy & rhabdomyolysis
**
Loss of 'Pro-Drug' efficacy
Quinidine (CYP2D6 Inhibitor)
Codeine (prodrug) :no_entry:> Morphine (analgesic)
Paraxetine (CYP2D6 Inhibitor)
Tramodol (prodrug) :no_entry:> O-desmethyltramadol (analgesic)
Fluoxetine / Paroxetine (CYP2D6 Inhibitor)
Tamoxifen
:no_entry:> active metabolite
Blood levels of drug (low dose) increases to therapeutic levels
Diltiazem (CYP3A4 Inhibitor)
[
Cyclosporin
] increases, low dosage required
Xanthine Oxidase (XO) metabolises 6-MP > Non-toxic
Allopurinol (XO Inhibitor)
AVOID with Azathioprine/Mercaptopurine (6-MP)
:forbidden: >Myelosuppression
Aldehyde dehydrogenase (ALDH) metabolises Ethanol > Non-toxic
Metronidazole (ALDH Inhibitor)
AVOID with Alcohol
:forbidden:> Disulfiram Reaction
Absorption
:!:
DDIs within GI Tract
Drugs bind to another, limiting oral bioavailability
Cholestyramine (Questran)
Bind to
Digoxin
Thyroxine
Warfarin
Drugs form Insoluble precipitate
Antacids + Quinolones
Calcium/Iron Ions + Tetracyclines
Changes in GT - Tract pH
Decrease acidity with Proton Pump Inhibitors
Absorption of Drugs decrease
Ketoconazole
Itraconazole
Erlotinib
Changes in GI Tract motility
GI Absorption slowed by drugs that delay gastric emptying
Atropine
Opiates
GI absorption accelerated by drugs that stimulate gastric emptying
Metoclopramide (Maxolon)
Interference with Drug Transporters P-Gp - promote excretion of drugs into intestinal lumen :!:
P-Glycoprotein Inhibitors
Block Efflux transporting function; :arrow_up:Drug Absorption
P-Glycoprotein Substrates
HIV protease inhibitors
Cyclosporin
Quinidine
Digoxin
:!: :no_entry:
P-Glycoprotein Inhibitors
Quinidine
:no_entry:
AVOID with Digoxin; Quinidine will increase Plasma [Digoxin] > CNS Toxicity
:!: :forbidden:
Cyclosporin
Fluoxetine
Diltiazem
Itraconazole
P-Glycoprotein Inducers
Enhance Efflux transporting function; :arrow_down:Drug Absorption
P-Gp Inducers
Rifampicin
:!:
St John's Wort
:!:
AVOID with Digoxin; decrease [Digoxin] :forbidden:
Excretion
Renal Tubular Secretion
Probenecid (Inhibits Renal Secretion)
Beneficial
with Penicillin (prolong action) :check:
Deleterious
with Methotrexate (Increase Toxicity) :forbidden:
Problematic Drugs (Narrow therapeutic Index)
Warfarin
Lithium
Digoxin